SAMHD1 and diffuse large B-cell lymphoma: Similarly, SUDHL-4, another DLBCL cell line with higher SAMHD1 expression, was sensitized to doxorubicin treatment following Vpx-mediated SAMHD1 degradation and siRNA-mediated SAMHD1 depletion (Supplementary Figure S2D-F).